Current perspectives on inhibitory SMAD7 in health and disease

References

• Abdollah S, Macías-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL. 1997. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem. 272(44):27678–27685.
   PubMed Web of Science ®Google Scholar
• Afrakhte M, Morén A, Jossan S, Itoh S, Sampath K, Westermark B, Heldin CH, Heldin NE, Ten Dijke P. 1998. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members . Biochem Biophys Res Commun. 249(2):505–511.
   PubMed Web of Science ®Google Scholar
• Akhurst RJ, Hata A. 2012. Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov. 11(10):790–811.
   PubMed Web of Science ®Google Scholar
• Akimov V, Barrio-Hernandez I, Hansen SVF, Hallenborg P, Pedersen A-K, Bekker-Jensen DB, Puglia M, Christensen SDK, Vanselow JT, Nielsen MM, et al. 2018. UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 25(7):631–640. [accessed Jun 14]..
   PubMed Web of Science ®Google Scholar
• Alliston T, Ko TC, Cao Y, Liang YY, Feng XH, Chang C, Derynck R. 2005. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. J Biol Chem. 280(25):24227–24237.
   PubMed Web of Science ®Google Scholar
• Al-Salihi MA, Herhaus L, MacArtney T, Sapkota GP. 2012. USP11 augments TGFβ signaling by deubiquitylating ALK5. Open Biol. 2(6):120063.
   PubMed Web of Science ®Google Scholar
• Ambros V. 2004. The functions of animal microRNAs. Nature. 431(7006):350–355.
   PubMed Web of Science ®Google Scholar
• Aragón E, Goerner N, Xi Q, Gomes T, Gao S, Massagué J, MacIas MJ. 2012. Structural basis for the versatile interactions of Smad7 with regulator WW domains in TGF-β pathways. Structure. 20(10):1726–1736.
   PubMed Web of Science ®Google Scholar
• Ardizzone S, Bevivino G, Monteleone G. 2016. Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease. Therap Adv Gastroenterol. 9(4):527–532.
   PubMed Web of Science ®Google Scholar
• Ayub SG, Kaul D. 2017. miR-2909 regulates ISGylation system via STAT1 signalling through negative regulation of SOCS3 in prostate cancer. Andrology. 5(4):790–797.
   PubMed Web of Science ®Google Scholar
• Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, Sakamoto T, Kiyama S, Kiyama Y, Ubai T, et al. 2005. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst. 97(23):1734–1746
   PubMedGoogle Scholar
• Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Batlle E, Massagué J. 2019. Transforming growth factor-β signaling in immunity and cancer. Immunity. 50(4):924–940.
   PubMed Web of Science ®Google Scholar
• Bewtra M, Lichtenstein GR. 2020. Mongersen and SMAD-7 Inhibition, Not a Lucky 7 for Patients With IBD. Am J Gastroenterol. :1.
   PubMed Web of Science ®Google Scholar
• Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, Böttinger EP. 2000. A mechanism of suppression of TGF-β/SMAD signaling by NF-kappa B/RelA. Genes Dev. 14(2):187–197.
   PubMed Web of Science ®Google Scholar
• Boirivant M, Pallone F, Di Giacinto C, Fina D, Monteleone I, Marinaro M, Caruso R, Colantoni A, Palmieri G, Sanchez M, et al. 2006. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-β1-mediated suppression of colitis. Gastroenterology. 131(6):1786–1798.
   PubMed Web of Science ®Google Scholar
• Broderick P, Carvajal-Carmona L, Pittman AM, Webb E, Howarth K, Rowan A, Lubbe S, Spain S, Sullivan K, Fielding S, CORGI Consortium, et al. 2007. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet. 39(11):1315–1317.
   PubMed Web of Science ®Google Scholar
• Brodin G, Åhgren A, Ten Dijke P, Heldin CH, Heuchel R. 2000. Efficient TGF-β induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter . J Biol Chem. 275(37):29023–29030.
   PubMed Web of Science ®Google Scholar
• Bu P, Wang L, Chen KY, Rakhilin N, Sun J, Closa A, Tung KL, King S, Varanko AK, Xu Y, et al. 2015. miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β. Nat Commun. 6(1).
   Google Scholar
• Casado P, Alcolea MP, Iorio F, Rodríguez-Prados JC, Vanhaesebroeck B, Saez-Rodriguez J, Joel S, Cutillas PR. 2013. Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors. Genome Biol. 14(4):R37.
   PubMed Web of Science ®Google Scholar
• Chang CH, Yen MC, Liao SH, Hsu YL, Lai CS, Kuo YR, Hsu YL. 2017. Dual role of MiR-21-mediated signaling in HUVECs and rat surgical flap under normoxia and hypoxia condition. Int J Mol Sci. 18(9)
   Web of Science ®Google Scholar
• Chang L, Yuan Y, Li C, Guo T, Qi H, Xiao Y, Dong X, Liu Z, Liu Q. 2016. Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma. Cancer Lett. 383(2):183–194.
   PubMed Web of Science ®Google Scholar
• Chang Y, Liu C, Yang J, Liu G, Feng F, Tang J, Hu L, Li L, Jiang F, Chen C, et al. 2013. MiR-20a triggers metastasis of gallbladder carcinoma. J Hepatol. 59(3):518–527.
   PubMed Web of Science ®Google Scholar
• Chao LI, Hua-Yu ZHU, Wen-Dong BAI, Mei S, Bin X, Da-Hai HU, Yi LIU. 2019. miR-96 promotes collagen deposition in keloids by targeting Smad7. Exp Ther Med. 17(1):773–781.
   PubMed Web of Science ®Google Scholar
• Che H, Wang Y, Li Y, Lv J, Li H, Liu Y, Dong R, Sun Y, Xu X, Zhao J, et al. 2020. Inhibition of microRNA-150-5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts. J Cell Physiol. 235(11):7769–7779.
   PubMed Web of Science ®Google Scholar
• Chen B, Chen X, Wu X, Wang X, Wang Y, Lin TY, Kurata J, Wu J, Vonderfecht S, Sun G, et al. 2015. Disruption of microRNA-21 by TALEN leads to diminished cell transformation and increased expression of cell-environment interaction genes. Cancer Lett. 356(2 Pt B):506–516.
   PubMed Web of Science ®Google Scholar
• Chen E, Li Q, Wang H, Yang F, Min L, Yang J. 2018. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study. Biomed Pharmacother. 106:1370–1377.
   PubMed Web of Science ®Google Scholar
• Chen G, Cao S, Liu F, Liu Y. 2015. miR-195 plays a role in steroid resistance of ulcerative colitis by targeting Smad7. Biochem J. 471(3):357–367.
   PubMedGoogle Scholar
• Chen G, Huang S, Song F, Zhou Y, He X. 2020. Lnc-Ang362 is a pro-fibrotic long non-coding RNA promoting cardiac fibrosis after myocardial infarction by suppressing Smad7. Arch Biochem Biophys. 685:108354.
   PubMed Web of Science ®Google Scholar
• Chen L, Li Y, Fu Y, Peng J, Mo MH, Stamatakos M, Teal CB, Brem RF, Stojadinovic A, Grinkemeyer M, et al. 2013. Role of deregulated microRNAs in breast cancer progression using FFPE tissue. PLoS One. 8(1):e54213.
   PubMed Web of Science ®Google Scholar
• Chen Y, Sun C, Lu J, Zou L, Hu M, Yang Z, Xu Y. 2019. MicroRNA-590-5p antagonizes the inhibitory effect of high glucose on osteoblast differentiation by suppressing Smad7 in MC3T3-E1 cells. J Int Med Res. 47(4):1740–1748.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang Q, Zhou Y, Yang Z, Tan M. 2020. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway. Hum Exp Toxicol. 39(5):683–695.
   PubMed Web of Science ®Google Scholar
• Chong PA, Lin H, Wrana JL, Forman-Kay JD. 2006. An expanded WW domain recognition motif revealed by the interaction between Smad7 and the E3 ubiquitin ligase Smurf2. J Biol Chem. 281(25):17069–17075.
   PubMed Web of Science ®Google Scholar
• Chung ACK, Huang XR, Zhou L, Heuchel R, Lai KN, Lan HY. 2009. Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant. 24(5):1443–1454.
   PubMed Web of Science ®Google Scholar
• Clevers H, Nusse R. 2012. Wnt/β-catenin signaling and disease. Cell. 149(6):1192–1205.
   PubMed Web of Science ®Google Scholar
• Cutts AJ, Soond SM, Powell S, Chantry A. 2011. Early phase TGFβ receptor signalling dynamics stabilised by the deubiquitinase UCH37 promotes cell migratory responses. Int J Biochem Cell Biol. 43(4):604–612.
   PubMed Web of Science ®Google Scholar
• Dai F, Liu T, Zheng S, Liu Q, Yang C, Zhou J, Chen Y, Sheyhidin I, Lu X. 2016. MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh's esophageal squamous cell carcinoma. Tumour Biol. 37(11):14595–14604.
   PubMedGoogle Scholar
• Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. 2010. Smad proteins bind a conserved RNA sequence to promote MicroRNA maturation by Drosha. Mol Cell. 39(3):373–384.
   PubMed Web of Science ®Google Scholar
• De Simone V, Bevivino G, Sedda S, Izzo R, Laudisi F, Dinallo V, Franzè E, Colantoni A, Ortenzi A, Salvatori S, et al. 2017. Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death. Cell Death Dis. 8(3):e2681–e2681.
   PubMedGoogle Scholar
• Derynck R, Budi EH. 2019. Specificity, versatility, and control of TGF-b family signaling. Sci Signal. 12(570):eaav5183.
   PubMed Web of Science ®Google Scholar
• Derynck R, Zhang Y, Feng XH. 1998. Smads: Transcriptional activators of TGF-β responses. Cell. 95(6):737–740.
   PubMed Web of Science ®Google Scholar
• Dooley S, Hamzavi J, Ciuclan L, Godoy P, Ilkavets I, Ehnert S, Ueberham E, Gebhardt R, Kanzler S, Geier A, et al. 2008. Hepatocyte-Specific Smad7 Expression Attenuates TGF-β-Mediated Fibrogenesis and Protects Against Liver Damage. Gastroenterology. 135(2):642–659.e46.
   PubMed Web of Science ®Google Scholar
• Dooley S, Said HM, Gressner AM, Floege J, En-Nia A, Mertens PR. 2006. Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J Biol Chem. 281(3):1784–1795.
   PubMed Web of Science ®Google Scholar
• Dowdy SC, Mariani A, Janknecht R. 2003. HER2/Neu- and TAK1-mediated Up-regulation of the Transforming Growth Factor β inhibitor Smad7 via the ETS protein ER81. J Biol Chem. 278(45):44377–44384.
   PubMed Web of Science ®Google Scholar
• Du J, Zheng R, Xiao F, Zhang S, He K, Zhang J, Shao Y. 2017. Downregulated microRNA-195 in the bicuspid aortic valve promotes calcification of valve interstitial cells via targeting SMAD7. Cell Physiol Biochem. 44(3):884–896.
   PubMedGoogle Scholar
• Duan Y, Chen Q. 2016. TGF-β1 regulating MIR-205/MIR-195 expression affects the TGF-β signal pathway by respectively targeting SMAD2/SMAD7. Oncol Rep. 36(4):1837–1844.
   PubMed Web of Science ®Google Scholar
• Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K. 2001. Smurf1 Interacts with Transforming Growth factor-β type I receptor through Smad7 and induces receptor degradation. J Biol Chem. 276(16):12477–12480.
   PubMed Web of Science ®Google Scholar
• Edlund S, Bu S, Schuster N, Aspenström P, Heuchel R, Heldin NE, Ten Dijke P, Heldin CH, Landström M. 2003. Transforming growth factor-β1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell. 14(2):529–544.
   PubMed Web of Science ®Google Scholar
• Edlund S, Lee SY, Grimsby S, Zhang S, Aspenström P, Heldin C-H, Landström M. 2005. Interaction between Smad7 and β-catenin: importance for transforming growth factor β-induced apoptosis. Mol Cell Biol. 25(4):1475–1488.
   PubMed Web of Science ®Google Scholar
• Eichhorn PJA, Rodón L, Gonzàlez-Juncà A, Dirac A, Gili M, Martínez-Sáez E, Aura C, Barba I, Peg V, Prat A, et al. 2012. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nat Med. 18(3):429–435.
   PubMed Web of Science ®Google Scholar
• Elkouris M, Kontaki H, Stavropoulos A, Antonoglou A, Nikolaou KC, Samiotaki M, Szantai E, Saviolaki D, Brown PJ, Sideras P, et al. 2016. SET9-mediated regulation of TGF-β signaling links protein methylation to pulmonary fibrosis. Cell Rep. 15(12):2733–2744.
   PubMed Web of Science ®Google Scholar
• Ezzie ME, Crawford M, Cho JH, Orellana R, Zhang S, Gelinas R, Batte K, Yu L, Nuovo G, Galas D, et al. 2012. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax. 67(2):122–131.
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. 2010. Regulation of mRNA Translation and Stability by microRNAs. Annu Rev Biochem. 79(1):351–379.
   PubMed Web of Science ®Google Scholar
• Fang SH, Chen L, Chen HH, Li YF, Luo HB, Hu DQ, Chen P. 2019. MiR-15b ameliorates SONFH by targeting Smad7 and inhibiting osteogenic differentiation of BMSCs. Eur Rev Med Pharmacol Sci. 23(22):9761–9771.
   PubMed Web of Science ®Google Scholar
• Fantini MC, Rizzo A, Fina D, Caruso R, Sarra M, Stolfi C, Becker C, MacDonald TT, Pallone F, Neurath MF, et al. 2009. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology. 136(4):1308–1316.e3.
   PubMed Web of Science ®Google Scholar
• Feagan BG, Sands BE, Rossiter G, Li X, Usiskin K, Zhan X, Colombel JF. 2018. Effects of Mongersen (GED-0301) on endoscopic and clinical outcomes in patients with active Crohn’s disease. Gastroenterology. 154(1):61–64.e6.
   PubMed Web of Science ®Google Scholar
• Feng M, Tang PMK, Huang XR, Sun SF, You YK, Xiao J, Lv LL, Xu AP, Lan HY. 2018. TGF-β mediates renal fibrosis via the Smad3-Erbb4-IR long noncoding RNA axis. Mol Ther. 26(1):148–161.
   PubMed Web of Science ®Google Scholar
• Feng T, Dzieran J, Yuan X, Dropmann A, Maass T, Teufel A, Marhenke S, Gaiser T, Rückert F, Kleiter I, et al. 2017. Hepatocyte-specific Smad7 deletion accelerates DEN-induced HCC via activation of STAT3 signaling in mice. Oncogenesis. 6(1):e294
   PubMedGoogle Scholar
• Feng YH, Tsao CJ. 2016. Emerging role of microRNA-21 in cancer. Biomed Rep. 5(4):395–402.
   PubMed Web of Science ®Google Scholar
• Ferrigno O, Lallemand F, Verrecchia F, L'Hoste S, Camonis J, Atfi A, Mauviel A. 2002. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling. Oncogene. 21(32):4879–4884.
   PubMed Web of Science ®Google Scholar
• Fortini BK, Tring S, Plummer SJ, Edlund CK, Moreno V, Bresalier RS, Barry EL, Church TR, Figueiredo JC, Casey G. 2014. Multiple functional risk variants in a SMAD7 enhancer implicate a colorectal cancer risk haplotype. PLoS One. 9(11):e111914.
   PubMed Web of Science ®Google Scholar
• Fu Y, Tang Y, Wang J, Guo Z. 2019. MicroRNA-181c suppresses the biological progression of osteosarcoma via targeting smad7 and regulating transforming growth factor-β (TGF-β) signaling pathway. Med Sci Monit. 25:4801–4810.
   PubMed Web of Science ®Google Scholar
• Gao X, Xu H, Xu D, Li S, Wei Z, Li S, Cai W, Mao N, Jin F, Li Y. 2020. MiR-411–3p alleviates Silica-induced pulmonary fibrosis by regulating Smurf2/TGF-β signaling. Exp Cell Res. 388(2).
   Web of Science ®Google Scholar
• Garo LP, Ajay AK, Fujiwara M, Beynon V, Kuhn C, Gabriely G, Sadhukan S, Raheja R, Rubino S, Weiner HL, et al. 2019. Smad7 controls immunoregulatory PDL2/1-PD1 signaling in intestinal inflammation and autoimmunity. Cell Rep. 28(13):3353–3366.e5.
   PubMed Web of Science ®Google Scholar
• Garros RF, Paul R, Connolly M, Lewis A, Garfield BE, Natanek SA, Bloch S, Mouly V, Griffiths MJ, Polkey MI, et al. 2017. MicroRNA-542 promotes mitochondrial dysfunction and SMAD activity and is elevated in intensive care unit-acquired Weakness. Am J Respir Crit Care Med. 196(11):1422–1433.
   PubMed Web of Science ®Google Scholar
• Ghorbani S, Talebi F, Chan WF, Masoumi F, Vojgani M, Power C, Noorbakhsh F. 2017. MicroRNA-181 variants regulate T cell phenotype in the context of autoimmune neuroinflammation. Front Immunol. 8:758.
   PubMed Web of Science ®Google Scholar
• Gohla G, Krieglstein K, Spittau B. 2008. Tieg3/Klf11 induces apoptosis in OLI-neu cells and enhances the TGF-β signaling pathway by transcriptional repression of Smad7. J Cell Biochem. 104(3):850–861.
   PubMed Web of Science ®Google Scholar
• Grau AM, Datta PK, Zi J, Halder SK, Beauchamp RD. 2006. Role of Smad proteins in the regulation of NF-kappaB by TGF-β in colon cancer cells. Cell Signal. 18(7):1041–1050.
   PubMed Web of Science ®Google Scholar
• Grönroos E, Hellman U, Heldin CH, Ericsson J. 2002. Control of Smad7 stability by competition between acetylation and ubiquitination. Mol Cell. 10(3):483–493.
   PubMed Web of Science ®Google Scholar
• Gu W, Hong X, Le Bras A, Nowak WN, Bhaloo SI, Deng J, Xie Y, Hu Y, Ruan XZ, Xu Q. 2018. Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts. J Biol Chem. 293(21):8089–8102.
   PubMed Web of Science ®Google Scholar
• Ha Thi HT, Kim H-Y, Choi S-W, Kang J-M, Kim S-J, Hong S. 2015. Smad7 Modulates Epidermal Growth Factor Receptor Turnover through Sequestration of c-Cbl. Mol Cell Biol. 35(16):2841–2850.
   PubMed Web of Science ®Google Scholar
• Ha Thi HT, Kim H-Y, Lee Y-J, Kim S-J, Hong S. 2019. SMAD7 in keratinocytes promotes skin carcinogenesis by activating ATM-dependent DNA repair and an EGFR-mediated cell proliferation pathway | Carcinogenesis | Oxford Academic. Carcinogenesis. 40(1):112–120.
   PubMed Web of Science ®Google Scholar
• Halder SK, Beauchamp RD, Datta PK. 2005. Smad7 induces tumorigenicity by blocking TGF-β-induced growth inhibition and apoptosis. Exp Cell Res. 307(1):231–246.
   PubMed Web of Science ®Google Scholar
• Halder SK, Rachakonda G, Deane NG, Datta PK. 2008. Smad7 induces hepatic metastasis in colorectal cancer. Br J Cancer. 99(6):957–965.
   PubMed Web of Science ®Google Scholar
• Hamzavi J, Ehnert S, Godoy P, Ciuclan L, Weng H, Mertens PR, Heuchel R, Dooley S. 2008. Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice. J Cell Mol Med. 12(5B):2130–2144.
   PubMed Web of Science ®Google Scholar
• Han G, Li AG, Liang YY, Owens P, He W, Lu S, Yoshimatsu Y, Wang D, ten Dijke P, Lin X, et al. 2006. Smad7-Induced β-catenin degradation alters epidermal appendage development. Dev Cell. 11(3):301–312.
   PubMed Web of Science ®Google Scholar
• Hanyu A, Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K. 2001. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling. J Cell Biol. 155(6):1017–1027.
   PubMed Web of Science ®Google Scholar
• Hariharan R, Pillai MR. 2008. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence. Proteins Struct Funct Genet. 71(4):1853–1862.
   PubMed Web of Science ®Google Scholar
• Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA, Wrana JL, et al. 1997. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell. 89(7):1165–1173.
   PubMed Web of Science ®Google Scholar
• He G, Chen J, Huang D. 2019. miR-877-3p promotes TGF-β1-induced osteoblast differentiation of MC3T3-E1 cells by targeting Smad7. Exp Ther Med. 18(1):312–319
   PubMed Web of Science ®Google Scholar
• He J, Sun X, Qian KQ, Liu X, Wang Z, Chen Y. 2009. Protection of cerulein-induced pancreatic fibrosis by pancreas-specific expression of Smad7. Biochim Biophys Acta - Mol Basis Dis. 1792(1):56–60.
   Web of Science ®Google Scholar
• Heldin CH, Moustakas A. 2016. Signaling receptors for TGF-β family members. Cold Spring Harb Perspect Biol. 8(8):a022053.
   PubMed Web of Science ®Google Scholar
• Herhaus L, Sapkota GP. 2014. The emerging roles of deubiquitylating enzymes (DUBs) in the TGFβ and BMP pathways. Cell Signal. 26(10):2186–2192.
   PubMed Web of Science ®Google Scholar
• Hill CS. 2016. Transcriptional control by the SMADs. Cold Spring Harb Perspect Biol. 8(10):a022079.
   PubMed Web of Science ®Google Scholar
• Hong S, Lim S, Li AG, Lee C, Lee YS, Lee EK, Park SH, Wang XJ, Kim SJ. 2007. Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol. 8(5):504–513.
   PubMed Web of Science ®Google Scholar
• Hsu YL, Huang MS, Hung JY, Chang WA, Tsai YM, Pan YC, Lin YS, Tsai HP, Kuo PL. 2020. Bone-marrow-derived cell-released extracellular vesicle miR-92a regulates hepatic pre-metastatic niche in lung cancer. Oncogene. 39(4):739–753.
   PubMed Web of Science ®Google Scholar
• Hu B, Mao Z, Du Q, Jiang X, Wang Z, Xiao Z, Zhu D, Wang X, Zhu Y, Wang H. 2019. miR-93-5p targets Smad7 to regulate the transforming growth factor-β1/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma. Brain Res Bull. 149:21–31.
   PubMed Web of Science ®Google Scholar
• Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND, Zhao YY. 2018. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact. 292:76–83.
   PubMed Web of Science ®Google Scholar
• Hu J, Xu J-F, Ge W-L. 2016. MiR-497 enhances metastasis of oral squamous cell carcinoma through SMAD7 suppression. Am J Transl Res. 8(7):3023–3031.
   PubMed Web of Science ®Google Scholar
• Hua X, Miller ZA, Benchabane H, Wrana JL, Lodish HF. 2000. Synergism between transcription factors TFE3 and Smad3 in transforming growth factor-β-induced transcription of the Smad7 gene. J Biol Chem. 275(43):33205–33208.
   PubMed Web of Science ®Google Scholar
• Huang C, Song H, Lai L. 2019. The role and mechanism of microRNA-18a-5p in oral squamous cell carcinoma. Mol Med Rep. 20(2):1637–1644.
   PubMed Web of Science ®Google Scholar
• Huang CF, Sun CC, Zhao F, Zhang YD, Li DJ. 2015. miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis. J Gastroenterol. 50(4):480–490.
   PubMed Web of Science ®Google Scholar
• Huang N, Li W, Wang X, Qi S. 2018. MicroRNA-17-5p aggravates lipopolysaccharide-induced injury in nasal epithelial cells by targeting Smad7. BMC Cell Biol. 19(1):1
   PubMedGoogle Scholar
• Huang S, Yang B, Chen BJ, Bliim N, Ueberham U, Arendt T, Janitz M. 2017. The emerging role of circular RNAs in transcriptome regulation. Genomics. 109(5-6):401–407.
   PubMed Web of Science ®Google Scholar
• Huang W, Yang Y, Wu J, Niu Y, Yao Y, Zhang J, Huang X, Liang S, Chen R, Chen S, et al. 2020. Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-β signalling. Cell Death Differ. 27(5):1709–1727.
   PubMed Web of Science ®Google Scholar
• Hujie G, Zhou S. H, Zhang H, Qu J, Xiong X, Wei Hujie O, Liao C. G, Yang S. E. 2018. MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/KLF11/Smads in hepatocellular carcinoma. Cancer Cell Int. 18(1):10.
   PubMed Web of Science ®Google Scholar
• Ibarrola N, Kratchmarova I, Nakajima D, Schiemann WP, Moustakas A, Pandey A, Mann M. 2004. Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor β signaling. BMC Cell Biol. 5:2.
   PubMedGoogle Scholar
• Ihara S, Hirata Y, Koike K. 2017. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota. J Gastroenterol. 52(7):777–787.
   PubMed Web of Science ®Google Scholar
• Imamura T, Oshima Y, Hikita A. 2013. Regulation of TGF-β family signalling by ubiquitination and deubiquitination. J Biochem. 154(6):481–489.
   PubMed Web of Science ®Google Scholar
• Inamitsu M, Itoh S, Hellman U, ten Dijke P, Kato M. 2006. Methylation of Smad6 by protein arginine N-methyltransferase 1. FEBS Lett. 580(28-29):6603–6611.
   PubMed Web of Science ®Google Scholar
• Itoh S, Landström M, Hermansson A, Itoh F, Heldin CH, Heldin NE, Ten Dijke P. 1998. Transforming growth factor β1 induces nuclear export of inhibitory Smad7. J Biol Chem. 273(44):29195–29201.
   PubMed Web of Science ®Google Scholar
• Itoh S, ten Dijke P. 2007. Negative regulation of TGF-β receptor/Smad signal transduction. Curr Opin Cell Biol. 19(2):176–184.
   PubMed Web of Science ®Google Scholar
• Jairath V, Zou G, Parker CE, MacDonald JK, Mosli MH, AlAmeel T, Al Beshir M, AlMadi M, Al-Taweel T, Atkinson NSS, et al. 2017. Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease. Aliment Pharmacol Ther. 45(8):1021–1042.
   PubMed Web of Science ®Google Scholar
• Javelaud D, Delmas V, Möller M, Sextius P, André J, Menashi S, Larue L, Mauviel A. 2005. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo. Oncogene. 24(51):7624–7629.
   PubMed Web of Science ®Google Scholar
• Javelaud D, Mohammad KS, McKenna CR, Fournier P, Luciani F, Niewolna M, André J, Delmas V, Larue L, Guise TA, et al. 2007. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Res. 67(5):2317–2324.
   PubMed Web of Science ®Google Scholar
• Jenkins BJ, Grail D, Nheu T, Najdovska M, Wang B, Waring P, Inglese M, McLoughlin RM, Jones SA, Topley N, et al. 2005. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling. Nat Med. 11(8):845–852.
   PubMed Web of Science ®Google Scholar
• Jia J, Feng X, Xu W, Yang S, Zhang Q, Liu X, Feng Y, Dai Z. 2014. MiR-17-5p modulates osteoblastic differentiation and cell proliferation by targeting SMAD7 in non-traumatic osteonecrosis. Exp Mol Med. 46(7):e107–e107.
   PubMedGoogle Scholar
• Jiao C, Li L, Zhang P, Zhang L, Li K, Fang R, Yuan L, Shi K, Pan L, Guo Q, et al. 2020a. REGγ ablation impedes dedifferentiation of anaplastic thyroid carcinoma and accentuates radio-therapeutic response by regulating the Smad7-TGF-β pathway. Cell Death Differ. 27(2):497–508.
   PubMed Web of Science ®Google Scholar
• Jiao C, Li L, Zhang P, Zhang L, Li K, Fang R, Yuan L, Shi K, Pan L, Guo Q, et al. 2020b. REGγ ablation impedes dedifferentiation of anaplastic thyroid carcinoma and accentuates radio-therapeutic response by regulating the Smad7-TGF-β pathway. Cell Death Differ. 27(2):497–508.
   PubMed Web of Science ®Google Scholar
• Jiao H, Xie D, Qiao Y. 2019. LncRNA PRINS is involved in the development of nephropathy in patients with diabetes via interaction with Smad7. Exp Ther Med. 17(4):3203–3208.
   PubMed Web of Science ®Google Scholar
• Jungert K, Buck A, Buchholz M, Wagner M, Adler G, Gress TM, Ellenrieder V. 2006. Smad-Sp1 complexes mediate TGFβ-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. Carcinogenesis. 27(12):2392–2401.
   PubMed Web of Science ®Google Scholar
• Kamato D, Burch ML, Piva TJ, Rezaei HB, Rostam MA, Xu S, Zheng W, Little PJ, Osman N. 2013. Transforming growth factor-β signalling: Role and consequences of Smad linker region phosphorylation. Cell Signal. 25(10):2017–2024.
   PubMed Web of Science ®Google Scholar
• Kan H, Guo W, Huang Y, Liu D. 2015. MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7. FEBS Lett. 589(1):102–109.
   PubMed Web of Science ®Google Scholar
• Katsuno Y, Qin J, Oses-Prieto J, Wang H, Jackson-Weaver O, Zhang T, Lamouille S, Wu J, Burlingame A, Xu J, et al. 2018. Arginine methylation of SMAD7 by PRMT1 in TGF-–induced epithelial–mesenchymal transition and epithelial stem-cell generation. J Biol Chem. 293(34):13059–137072.
   PubMed Web of Science ®Google Scholar
• Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF β receptor for degradation. Mol Cell. 6(6):1365–1375.
   PubMed Web of Science ®Google Scholar
• Kim VN, Han J, Siomi MC. 2009. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 10(2):126–139.
   PubMed Web of Science ®Google Scholar
• Kit Leng Lui S, Iyengar PV, Jaynes P, Isa ZFBA, Pang B, Tan TZ, Eichhorn PJA. 2017. USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7. EMBO Rep. 18(5):797–808.
   PubMed Web of Science ®Google Scholar
• Koinuma D, Shinozaki M, Komuro A, Goto K, Saitoh M, Hanyu A, Ebina M, Nukiwa T, Miyazawa K, Imamura T, et al. 2003. Arkadia amplifies TGF-β superfamily signalling through degradation of Smad7. Embo J. 22(24):6458–6470.
   PubMed Web of Science ®Google Scholar
• Kostopoulou F, Malizos KN, Papathanasiou I, Tsezou A. 2015. MicroRNA-33a regulates cholesterol synthesis and cholesterol efflux-related genes in osteoarthritic chondrocytes. Arthritis Res Ther. 17(1):42
   PubMedGoogle Scholar
• Kruse JJCM, Floot BGJ, Te Poele JAM, Russell NS, Stewart FA. 2009. Radiation-Induced Activation of TGF-β signaling pathways in relation to vascular damage in mouse kidneys. Radiat Res. 171(2):188–197.
   PubMed Web of Science ®Google Scholar
• Kuang C, Xiao Y, Liu X, Stringfield TM, Zhang S, Wang Z, Chen Y. 2006. In vivo disruption of TGF-β signaling by Smad7 leads to premalignant ductal lesions in the pancreas. Proc Natl Acad Sci USA. 103(6):1858–1863.
   PubMed Web of Science ®Google Scholar
• Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K, Imamura T. 2005. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor. Biochem J. 386(Pt 3):461–470.
   PubMedGoogle Scholar
• Lallemand F, Seo SR, Ferrand N, Pessah M, L'Hoste S, Rawadi G, Roman-Roman S, Camonis J, Atfi A. 2005. AIP4 restricts transforming growth factor-β signaling through a ubiquitination-independent mechanism. J Biol Chem. 280(30):27645–27653.
   PubMed Web of Science ®Google Scholar
• Lamora A, Talbot J, Bougras G, Amiaud J, Leduc M, Chesneau J, Taurelle J, Stresing V, Le Deley MC, Heymann MF, et al. 2014. Overexpression of Smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma. Clin Cancer Res. 20(19):5097–5112.
   PubMed Web of Science ®Google Scholar
• Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 129(7):1401–1414.
   PubMed Web of Science ®Google Scholar
• Leivonen SK, Ala-Aho R, Koli K, Grénman R, Peltonen J, Kähäri VM. 2006. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene. 25(18):2588–2600.
   PubMed Web of Science ®Google Scholar
• Li H, Li J, Chen L, Qi S, Yu S, Weng Z, Hu Z, Zhou Q, Xin Z, Shi L, et al. 2019. HERC3-Mediated SMAD7 ubiquitination degradation promotes autophagy-induced EMT and chemoresistance in Glioblastoma. Clin Cancer Res. 25(12):3602–3616.
   PubMed Web of Science ®Google Scholar
• Li PF, He RH, Shi SB, Li R, Wang QT, Rao GT, Yang B. 2019. Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation. Biosci Rep. 39(2):BSR20181931.
   PubMedGoogle Scholar
• Li Q, Zou C, Zou C, Han Z, Xiao H, Wei H, Wang W, Zhang L, Zhang X, Tang Q, et al. 2013. MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Lett. 335(1):168–174.
   PubMed Web of Science ®Google Scholar
• Li S, Fan Q, He S, Tang T, Liao Y, Xie J. 2015. MicroRNA-21 negatively regulates treg cells through a TGF-β1/smad-independent pathway in patients with coronary heart disease. Cell Physiol Biochem. 37(3):866–878.
   PubMedGoogle Scholar
• Li X, Guo L, Liu Y, Su Y, Xie Y, Du J, Wang S, Wang H, Liu Y. 2018. MicroRNA-21 promotes wound healing via the Smad7-Smad2/3-Elastin pathway. Exp Cell Res. 362(2):245–251.
   PubMed Web of Science ®Google Scholar
• Li X, Nania S, Fejzibegovic N, Moro CF, Klopp-Schulze L, Verbeke C, Löhr JM, Heuchel RL. 2016. Cerulein-induced pancreatic fibrosis is modulated by Smad7, the major negative regulator of transforming growth factor-β signaling. Biochim Biophys Acta - Mol Basis Dis. 1862(9):1839–1846.
   Web of Science ®Google Scholar
• Li X, Zeng X. 2020. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway. Cell Biol Int. 44(2):467–476.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang H, Li J, Yue W. 2014. MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7. Acta Biochim Biophys Sin (Shanghai)). 46(1):48–55.
   PubMed Web of Science ®Google Scholar
• Li Y, Xiang Y, Song Y, Wan L, Yu G, Tan L. 2019. Dysregulated miR-142, -33b and -423 in granulosa cells target TGFBR1 and SMAD7: a possible role in polycystic ovary syndrome. Mol Hum Reprod. 25(10):638–646.
   PubMed Web of Science ®Google Scholar
• Liang ZG, Yao H, Xie RS, Gong CL, Tian Y. 2018. MicroRNA-20b-5p promotes ventricular remodeling by targeting the TGF-β/Smad signaling pathway in a rat model of ischemia-reperfusion injury. Int J Mol Med. 42(2):975–987.
   PubMed Web of Science ®Google Scholar
• Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E. 2010. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 207(8):1589–1597.
   PubMed Web of Science ®Google Scholar
• Liu H, Li S, Jiang W, Li Y. 2020. MiR-484 protects rat myocardial cells from ischemia-reperfusion injury by inhibiting caspase-3 and caspase-9 during apoptosis. Korean Circ J. 50(3):250–263.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhou Y, Shi Z, Hu Y, Meng T, Zhang X, Zhang S, Zhang J. 2016. MicroRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7. DNA Cell Biol. 35(9):521–529.
   PubMed Web of Science ®Google Scholar
• Liu N, Jiao T, Huang Y, Liu W, Li Z, Ye X. 2015. Hepatitis B Virus Regulates Apoptosis and Tumorigenesis through the MicroRNA-15a-Smad7-Transforming Growth Factor β Pathway. J Virol. 89(5):2739–2749.
   PubMed Web of Science ®Google Scholar
• Liu T, Wu Y, Huang T, Zhang X, Cai Y. 2017. miR-590 promotes the proliferation of HUMSCs and induces ECM synthesis by targeting Smad7. Oncol Lett. 14(4):3941–3946.
   PubMed Web of Science ®Google Scholar
• Liu W, Rui H, Wang J, Lin S, He Y, Chen M, Li Q, Ye Z, Zhang S, Siu CC, et al. 2006. Axin is a scaffold protein in TGF-β signaling that promotes degradation of Smad7 by Arkadia. Embo J. 25(8):1646–1658.
   PubMed Web of Science ®Google Scholar
• Liu X, Lee J, Cooley M, Bhogte E, Hartley S, Glick A. 2003. Smad7 but not Smad6 Cooperates with Oncogenic ras to Cause Malignant Conversion in a Mouse Model for Squamous Cell Carcinoma. [place unknown].
   Google Scholar
• Liu Z, Huang XR, Chen HY, Fung E, Liu J, Lan HY. 2017. Deletion of angiotensin-converting enzyme-2 promotes hypertensive nephropathy by targeting smad7 for ubiquitin degradation. Hypertension. 70(4):822–830.
   PubMed Web of Science ®Google Scholar
• Li Y, Cui C, Feng X, Kielbasa S, Mei H, Van Dinther M, Van Dam H, Bauer A, Zhang L, Ten Dijke P. 2020. VprBP Mitigates TGF-β and Activin Signaling by Promoting Smurf1-mediated Type I Receptor Degradation. J Mol Cell Biol. 12(2):138–151.
   PubMed Web of Science ®Google Scholar
• Luo M, Tan X, Mu L, Luo Y, Li R, Deng X, Chen N, Ren M, Li Y, Wang L, et al. 2017. MiRNA-21 mediates the antiangiogenic activity of metformin through targeting PTEN and SMAD7 expression and PI3K/AKT pathway. Sci Rep. 7:43427.
   PubMed Web of Science ®Google Scholar
• Luo X, Ding Q, Wang M, Li Z, Mao K, Sun B, Pan Y, Wang Z, Zang YQ, Chen Y. 2010. In vivo disruption of TGF-β Signaling by Smad7 in airway epithelium alleviates allergic asthma but aggravates lung carcinogenesis in mouse. PLoS One. 5(4):e10149.
   PubMed Web of Science ®Google Scholar
• Luo X, Zhang D, Xie J, Su Q, He X, Bai R, Gao G, Pan W. 2018. MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7. Mol Ther Methods Clin Dev. 11:73–82.
   PubMed Web of Science ®Google Scholar
• Luwor RB, Baradaran B, Taylor LE, Iaria J, Nheu TV, Amiry N, Hovens CM, Wang B, Kaye AH, Zhu HJ. 2013. Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo. Oncogene. 32(19):2433–2441.
   PubMed Web of Science ®Google Scholar
• Lv H, Nan Z, Jiang P, Wang Z, Song M, Ding H, Liu D, Zhao G, Zheng Y, Hu Y. 2019. Vascular endothelial growth factor 165 inhibits pro-fibrotic differentiation of stromal cells via the DLL4/Notch4/smad7 pathway. Cell Death Dis. 10(9):1–17.
   Google Scholar
• Malonis RJ, Fu W, Jelcic MJ, Thompson M, Canter BS, Tsikitis M, Esteva FJ, Sánchez I. 2017. RNF11 sequestration of the E3 ligase SMURF2 on membranes antagonizes SMAD7 down-regulation of transforming growth factor β signaling. J Biol Chem. 292(18):7435–7451.
   PubMed Web of Science ®Google Scholar
• Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, Icardi MS, Christensen RN, Schmidt WN, McCaffrey AP. 2010. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest. 90(12):1727–1736.
   PubMed Web of Science ®Google Scholar
• Massagué J. 1998. TGF-β signal transduction. Annu Rev Biochem. 67(1):753–791.
   PubMedGoogle Scholar
• Massagué J. 2008. TGFβ in Cancer. Cell. 134(2):215–230.
   PubMed Web of Science ®Google Scholar
• Massagué J. 2012. TGFβ signalling in context. Nat Rev Mol Cell Biol. 13(10):616–630.
   PubMed Web of Science ®Google Scholar
• Massagué J, Wotton D. 2000. Transcriptional Control by the TGF-β/Smad Signaling System. Embo J. 19(8):1745–1754.
   PubMed Web of Science ®Google Scholar
• Matsuzaki K. 2011. Smad Phosphoisoform Signaling Specificity: The Right Place at the Right Time. Carcinogenesis. 32(11):1578–1588.
   PubMed Web of Science ®Google Scholar
• Mazars A, Lallemand F, Prunier C, Marais J, Ferrand N, Pessah M, Cherqui G, Atfi A. 2001. Evidence for a role of the JNK cascade in Smad7-mediated apoptosis. J Biol Chem. 276(39):36797–36803.
   PubMed Web of Science ®Google Scholar
• Meng Z, Moroishi T, Guan KL. 2016. Mechanisms of Hippo pathway regulation. Genes Dev. 30(1):1–17.
   PubMed Web of Science ®Google Scholar
• Miyazawa K, Miyazono K. 2017. Regulation of TGF-β family signaling by inhibitory smads. Cold Spring Harb Perspect Biol. 9(3):a022095.
   PubMed Web of Science ®Google Scholar
• Mochizuki T, Miyazaki H, Hara T, Furuya T, Imamura T, Watabe T, Miyazono K. 2004. Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-β superfamily signaling. J Biol Chem. 279(30):31568–31574.
   PubMed Web of Science ®Google Scholar
• Monteleone G, Del Vecchio Blanco G, Monteleone I, Fina D, Caruso R, Gioia V, Ballerini S, Federici G, Bernardini S, Pallone F, et al. 2005. Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology. 129(5):1420–1429.
   PubMed Web of Science ®Google Scholar
• Monteleone G, Fantini MC, Onali S, Zorzi F, Sancesario G, Bernardini S, Calabrese E, Viti F, Monteleone I, Biancone L, et al. 2012. Phase I clinical trial of SMAD7 knockdown using antisense oligonucleotide in patients with active Crohn's disease. Mol Ther. 20(4):870–876.
   PubMed Web of Science ®Google Scholar
• Monteleone I, Marafini I, Zorzi F, Fusco DD, Dinallo V, Rizzo A, Sileri P, Sica G, Monteleone G. 2016. Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut. J Crohns Colitis. 10(6):670–677.
   PubMed Web of Science ®Google Scholar
• Morikawa M, Derynck R, Miyazono K. 2016. TGF- β and the TGF-β family: Context-dependent roles in cell and tissue physiology. Cold Spring Harb Perspect Biol. 8(5):a021873.
   PubMed Web of Science ®Google Scholar
• Mota MS, Jackson WP, Bailey SK, Vayalil P, Landar A, Rostas JW, Mulekar MS, Samant RS, Shevde LA. 2018. Deficiency of tumor suppressor merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer. Carcinogenesis. 39(9):1165–1175.
   PubMed Web of Science ®Google Scholar
• Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T. 2003. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell. 14(7):2809–2817.
   PubMed Web of Science ®Google Scholar
• Murugaiyan G, Da Cunha AP, Ajay AK, Joller N, Garo LP, Kumaradevan S, Yosef N, Vaidya VS, Weiner HL. 2015. MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J Clin Invest. 125(3):1069–1080.
   PubMed Web of Science ®Google Scholar
• Nagarajan RP, Chen F, Li W, Vig E, Harrington MA, Nakshatri H, Chen Y. 2000. Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κB. Biochem J. 348(3):591–596.
   PubMedGoogle Scholar
• Nagarajan RP, Zhang J, Li W, Chen Y. 1999. Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J Biol Chem. 274(47):33412–33418.
   PubMed Web of Science ®Google Scholar
• Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, et al. 1997. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature. 389(6651):631–635.
   PubMed Web of Science ®Google Scholar
• Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, Iwamoto I. 1999. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest. 104(1):5–11.
   PubMed Web of Science ®Google Scholar
• Napetschnig J, Wu H. 2013. Molecular basis of NF-κB signaling. Annu Rev Biophys. 42(1):443–468.
   PubMedGoogle Scholar
• Nong Q, Li S, Wu Y, Liu D. 2018. LncRNA COL1A2-AS1 inhibits the scar fibroblasts proliferation via regulating miR-21/Smad7 pathway. Biochem Biophys Res Commun. 495(1):319–324.
   PubMed Web of Science ®Google Scholar
• Ogunjimi AA, Briant DJ, Pece-Barbara N, Le Roy C, Di Guglielmo GM, Kavsak P, Rasmussen RK, Seet BT, Sicheri F, Wrana JL. 2005. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol Cell. 19(3):297–308.
   PubMed Web of Science ®Google Scholar
• Parikh A, Lee C, Joseph P, Marchini S, Baccarini A, Kolev V, Romualdi C, Fruscio R, Shah H, Wang F, et al. 2014. MicroRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Nat Commun. 5(1):1–16.
   Google Scholar
• Park S, Kang JM, Kim SJ, Kim H, Hong S, Lee YJ, Kim S-J. 2015. Smad7 enhances ATM activity by facilitating the interaction between ATM and Mre11-Rad50-Nbs1 complex in DNA double-strand break repair. Cell Mol Life Sci. 72(3):583–596.
   PubMed Web of Science ®Google Scholar
• Park SH, Jung EH, Kim GY, Kim BC, Lim JH, Woo CH. 2015. Itch E3 Ubiquitin Ligase Positively Regulates TGF-β Signaling to EMT via Smad7 Ubiquitination. Mol Cells. 38(1):20–25.
   PubMed Web of Science ®Google Scholar
• Patil S, Wildey GM, Brown TL, Choy L, Derynck R, Howe PH. 2000. Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-β -induced growth inhibition and apoptosis. J Biol Chem. 275(49):38363–38370.
   PubMed Web of Science ®Google Scholar
• Pearson G, Robinson F, Beers Gibson T, Xu B, Karandikar M, Berman K, Cobb MH. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions*. Endocr Rev. 22(2):153–183.
   PubMed Web of Science ®Google Scholar
• Pulaski L, Landström M, Heldin CH, Souchelnytskyi S. 2001. Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-β-dependent signaling but affects Smad7-dependent transcriptional activation. J Biol Chem. 276(17):14344–14349.
   PubMed Web of Science ®Google Scholar
• Pulignani S, Borghini A, Foffa I, Vecoli C, Ait-Alì L, Andreassi MG. 2020. Functional characterization and circulating expression profile of dysregulated microRNAs in BAV-associated aortopathy. Heart Vessels. 35(3):432–440.
   PubMed Web of Science ®Google Scholar
• Qin Z, Xia W, Fisher GJ, Voorhees JJ, Quan T. 2018. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts. Cell Commun Signal. 16(1):18
   PubMedGoogle Scholar
• Quan T, He T, Voorhees JJ, Fisher GJ. 2001. Ultraviolet Irradiation Blocks Cellular Responses to Transforming Growth factor-β by down-regulating its type-II receptor and inducing Smad7. J Biol Chem. 276(28):26349–26356.
   PubMed Web of Science ®Google Scholar
• Ratz L, Laible M, Kacprzyk LA, Wittig-Blaich SM, Tolstov Y, Duensing S, Altevogt P, Klauck SM, Sültmann H. 2017. TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells. Oncotarget. 8(15):25115–25130.
   PubMedGoogle Scholar
• Rawlings JS, Rosler KM, Harrison DA. 2004. The JAK/STAT signaling pathway. J Cell Sci. 117(Pt 8):1281–1283.
   PubMed Web of Science ®Google Scholar
• Rizzo A, De Mare V, Rocchi C, Stolfi C, Colantoni A, Neurath MF, Macdonald TT, Pallone F, Monteleone G, Fantini MC. 2014. Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells. Carcinogenesis. 35(7):1536–1546.
   PubMed Web of Science ®Google Scholar
• Rizzo A, Waldner MJ, Stolfi C, Sarra M, Fina D, Becker C, Neurath MF, Macdonald TT, Pallone F, Monteleone G, Fantini MC. 2011. Smad7 expression in T cells prevents colitis-associated cancer. Cancer Res. 71(24):7423–7432.
   PubMed Web of Science ®Google Scholar
• Rong X, Ge D, Shen D, Chen X, Wang X, Zhang L, Jia C, Zeng J, He Y, Qiu H, et al. 2018. MiR-27b suppresses endothelial cell proliferation and migration by targeting Smad7 in kawasaki disease. Cell Physiol Biochem. 48(4):1804–1814.
   PubMedGoogle Scholar
• Sands BE, Feagan BG, Sandborn WJ, Schreiber S, Peyrin-Biroulet L, Frédéric Colombel J, Rossiter G, Usiskin K, Ather S, Zhan X, et al. 2019. Mongersen (GED-0301) for Active Crohnʼs Disease: Results of a Phase 3 Study. Am J Gastroenterol. 115(5):738–745.
   Web of Science ®Google Scholar
• Scarozza P, Schmitt H, Monteleone G, Neurath MF, Atreya R. 2019. Oligonucleotides-A novel promising therapeutic option for IBD. Front Pharmacol. 10:314.
   PubMed Web of Science ®Google Scholar
• Sedda S, Franzè E, Bevivino GD, Giovangiulio M, Rizzo A, Colantoni A, Ortenzi A, Grasso E, Giannelli M, Sica GS, et al. 2018. Reciprocal regulation between Smad7 and Sirt1 in the gut. Front Immunol. 9:1854.
   PubMed Web of Science ®Google Scholar
• Shen DW, Li YL, Hou YJ, Xu ZD, Li YZ, Chang JY. 2019. MicroRNA-543 promotes cell invasion and impedes apoptosis in pituitary adenoma via activating the Wnt/β-catenin pathway by negative regulation of Smad7. Biosci Biotechnol Biochem. 83(6):1035–1044.
   PubMed Web of Science ®Google Scholar
• Shi JQ, Wang B, Cao XQ, Wang YX, Cheng X, Jia CL, Wen T, Luo BJ, Liu ZD. 2020. Circular RNA_LARP4 inhibits the progression of non-small-cell lung cancer by regulating the expression of SMAD7. Eur Rev Med Pharmacol Sci. 24(4):1863–1869.
   PubMed Web of Science ®Google Scholar
• Shi W, Sun C, He B, Xiong W, Shi X, Yao D, Cao X. 2004. GADD34-PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor. J Cell Biol. 164(2):291–300.
   PubMed Web of Science ®Google Scholar
• Shi X, Chen F, Yu J, Xu Y, Zhang S, Chen YG, Fang X. 2008. Study of interaction between Smad7 and DNA by single-molecule force spectroscopy. Biochem Biophys Res Commun. 377(4):1284–1287.
   PubMed Web of Science ®Google Scholar
• Shi Y, Massagué J. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell. 113(6):685–700.
   PubMed Web of Science ®Google Scholar
• Siebel C, Lendahl U. 2017. Notch signaling in development, tissue homeostasis, and disease. Physiol Rev. 97(4):1235–1294.
   PubMed Web of Science ®Google Scholar
• Sim WJ, Iyengar PV, Lama D, Lui SKL, Ng HC, Haviv-Shapira L, Domany E, Kappei D, Tan TZ, Saie A, et al. 2019. c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression. Nat Commun [Internet]. [accessed 2020 Sep 9] 10(1):1–19. /pmc/articles/PMC6761206/?report = abstract
   PubMedGoogle Scholar
• Simonsson M, Heldin CH, Ericsson J, Grönroos E. 2005. The balance between acetylation and deacetylation controls Smad7 stability. J Biol Chem. 280(23):21797–21803.
   PubMed Web of Science ®Google Scholar
• Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC, Ford HL. 2012. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene. 31(50):5162–5171.
   PubMed Web of Science ®Google Scholar
• Song C, Wang J, Ma Y, Yang Z, Dong D, Li H, Yang J, Huang Y, Plath M, Ma Y, et al. 2018. Linc-smad7 promotes myoblast differentiation and muscle regeneration via sponging miR-125b. Epigenetics. 13(6):591–604.
   PubMed Web of Science ®Google Scholar
• Song L-Y, Ma Y-T, Wu C-F, Wang C-J, Fang W-J, Liu S-K. 2017. MicroRNA-195 Activates Hepatic Stellate Cells In Vitro by Targeting Smad7. BioMed Res Int. 2017:1–12.
   Web of Science ®Google Scholar
• Song Y, Mou R, Li Y, Yang T. 2020. Zingerone Promotes Osteoblast Differentiation Via MiR-200c-3p/smad7 Regulatory Axis in Human Bone Mesenchymal Stem Cells. Med Sci Monit. 26:e919309
   PubMed Web of Science ®Google Scholar
• Souchelnytskyi S, Tamaki K, Engström U, Wernstedt CT, Dijke P, Heldin CH. 1997. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J Biol Chem. 272(44):28107–28115.
   PubMed Web of Science ®Google Scholar
• Stolfi C, De Simone V, Colantoni A, Franzè E, Ribichini E, Fantini MC, Caruso R, Monteleone I, Sica GS, Sileri P, et al. 2014. A functional role for Smad7 in sustaining colon cancer cell growth and survival. Cell Death Dis. 5(2):e1073
   PubMedGoogle Scholar
• Stolfi C, Marafini I, De Simone V, Pallone F, Monteleone G. 2013. The dual role of Smad7 in the control of cancer growth and metastasis. Int J Mol Sci. 14(12):23774–23790.
   PubMed Web of Science ®Google Scholar
• Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature. 403(6765):41–45.
   PubMed Web of Science ®Google Scholar
• Sun H, Peng Z, Tang H, Xie D, Jia Z, Zhong L, Zhao S, Ma Z, Gao Y, Zeng L, et al. 2017. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma. Oncogene [Internet]. [accessed 2020 Jun 21] 36(21):2957–2968. /pmc/articles/PMC5444978/?report = abstract
   PubMed Web of Science ®Google Scholar
• Suzuki C, Murakami G, Fukuchi M, Shimanuki T, Shikauchi Y, Imamura T, Miyazono K. 2002. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane. J Biol Chem. 277(42):39919–39925.
   PubMed Web of Science ®Google Scholar
• Tabata T, Kokura K, Ten Dijke P, Ishii S. 2009. Ski co-repressor complexes maintain the basal repressed state of the TGF-β target gene, SMAD7, via HDAC3 and PRMT5 . Genes Cells. 14(1):17–28.
   PubMed Web of Science ®Google Scholar
• Tang Q, Zou Z, Zou C, Zhang Q, Huang R, Guan X, Li Q, Han Z, Wang D, Wei H, et al. 2015. MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating. Tumour Biol. 36(3):1701–1710.
   PubMedGoogle Scholar
• Tang Y, Liu Z, Zhao L, Clemens TL, Cao X. 2008. Smad7 stabilizes β-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J Biol Chem. 283(35):23956–23963.
   PubMed Web of Science ®Google Scholar
• Tang Y, Reissig S, Glasmacher E, Regen T, Wanke F, Nikolaev A, Gerlach K, Popp V, Karram K, Fantini MC, et al. 2019. Alternative splice forms of CYLD mediate ubiquitination of SMAD7 to prevent TGFB signaling and promote colitis. Gastroenterology. 156(3):692–707.e7.
   PubMed Web of Science ®Google Scholar
• Tao J, Wang J, Li C, Wang W, Yu H, Liu J, Kong X, Chen Y. 2019. MiR-216a accelerates proliferation and fibrogenesis via targeting PTEN and SMAD7 in human cardiac fibroblasts. Cardiovasc Diagn Ther. 9(6):535–544.
   PubMed Web of Science ®Google Scholar
• Tenesa A, Farrington SM, Prendergast JGD, Porteous ME, Walker M, Haq N, Barnetson RA, Theodoratou E, Cetnarskyj R, Cartwright N, et al. 2008. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet. 40(5):631–637.
   PubMed Web of Science ®Google Scholar
• Tijsen AJ, van der Made I, van den Hoogenhof MM, Wijnen WJ, van Deel ED, de Groot NE, Alekseev S, Fluiter K, Schroen B, Goumans M-J, et al. 2014. The microRNA-15 Family Inhibits the TGFβ-pathway in the Heart. Cardiovasc Res. 104(1):61–71.
   PubMed Web of Science ®Google Scholar
• Tong L, Chu M, Yan B, Zhao W, Liu S, Wei W, Lou H, Zhang S, Ma S, Xu J, et al. 2017. MTDH promotes glioma invasion through regulating miR-130b-ceRNAs. Oncotarget. 8(11):17738–17749.
   PubMedGoogle Scholar
• Tong L, Shen S, Huang Q, Fu J, Wang T, Pan L, Zhang P, Chen G, Huang T, Li K, et al. 2020. Proteasome-dependent degradation of Smad7 is critical for lung cancer metastasis. Cell Death Differ. 27(6):1795–1806.
   PubMed Web of Science ®Google Scholar
• Topper JN, Cai J, Qiu Y, Anderson KR, Xu YY, Deeds JD, Feeley R, Gimeno CJ, Woolf EA, Tayber O, et al. 1997. Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci USA. 94(17):9314–9319.
   PubMed Web of Science ®Google Scholar
• Tsai TH, Sun MH, Ho TC, Ma HI, Liu MY, Tsao YP. 2014. Notch prevents transforming growth factor-β-assisted epithelial-mesenchymal transition in cultured limbal progenitor cells through the induction of Smad7. Mol Vis. 20:522–534.
   PubMed Web of Science ®Google Scholar
• Tsunobuchi H, Ishisaki A, Imamura T. 2004. Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells. Biochem Biophys Res Commun. 316(3):712–719.
   PubMed Web of Science ®Google Scholar
• Tu X, Zheng X, Li H, Cao Z, Chang H, Luan S, Zhu J, Chen J, Zang Y, Zhang J. 2015. MicroRNA-30 protects against carbon tetrachloride-induced liver fibrosis by attenuating transforming growth factor β signaling in hepatic stellate cells. Toxicol Sci. 146(1):157–169.
   PubMed Web of Science ®Google Scholar
• Tuncer E, Calçada RR, Zingg D, Varum S, Cheng P, Freiberger SN, Deng CX, Kleiter I, Levesque MP, Dummer R, et al. 2019. SMAD signaling promotes melanoma metastasis independently of phenotype switching. J Clin Invest. 129(7):2702–2716.
   PubMed Web of Science ®Google Scholar
• Uchida K, Suzuki H, Ohashi T, Nitta K, Yumura W, Nihei H. 2001. Involvement of MAP kinase cascades in Smad7 transcriptional regulation. Biochem Biophys Res Commun. 289(2):376–381.
   PubMed Web of Science ®Google Scholar
• Ulloa L, Doody J, Massagué J. 1999. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 397(6721):710–713.
   PubMed Web of Science ®Google Scholar
• Vishal M, Vimalraj S, Ajeetha R, Gokulnath M, Keerthana R, He Z, Partridge NC, Selvamurugan N. 2017. MicroRNA-590-5p stabilizes Runx2 by targeting Smad7 during osteoblast differentiation. J Cell Physiol. 232(2):371–380.
   PubMed Web of Science ®Google Scholar
• Von Gersdorff G, Susztak K, Rezvani F, Bitzer M, Liang D, Böttinger EP. 2000. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor β. J Biol Chem. 275(15):11320–11326.
   PubMed Web of Science ®Google Scholar
• Wahl LC, Watt JE, Yim HTT, De Bourcier D, Tolchard J, Soond SM, Blumenschein TMA, Chantry A. 2019. Smad7 Binds Differently to Individual and Tandem WW3 and WW4 Domains of WWP2 Ubiquitin Ligase Isoforms. Int J Mol Sci. 20(19):4682.
   Web of Science ®Google Scholar
• Wang C, Gu S, Cao H, Li Z, Xiang Z, Hu K, Han X. 2016. MiR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosis. Sci Rep. 6(1):1–11.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang J, Yang X, Chen D, Wang L. 2016. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT. Diagn Pathol. 11(1):1–9.
   PubMedGoogle Scholar
• Wang H, Nie L, Wu L, Liu Q, Guo X. 2017. NR2F2 inhibits Smad7 expression and promotes TGF-β-dependent epithelial-mesenchymal transition of CRC via transactivation of miR-21. Biochem Biophys Res Commun. 485(1):181–188.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao J, Chu ESH, Mok MTS, Go MYY, Man K, Heuchel R, Lan HY, Chang Z, Sung JJY, et al. 2013. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro. J Pathol. 230(4):441–452.
   PubMed Web of Science ®Google Scholar
• Wang M, Jia M, Yuan K. 2018. MicroRNA-663b promotes cell proliferation and epithelial mesenchymal transition by directly targeting SMAD7 in nasopharyngeal carcinoma. Exp Ther Med. 16(4):3129–3134.
   PubMed Web of Science ®Google Scholar
• Wang M, Saha J, Hada M, Anderson JA, Pluth JM, O'Neill P, Cucinotta FA. 2013. Novel Smad proteins localize to IR-induced double-strand breaks: interplay between TGFβ and ATM pathways. Nucleic Acids Res. 41(2):933–942.
   PubMed Web of Science ®Google Scholar
• Wang L, Geng J, Sun B, Sun C, Shi Y, Yu X. 2020. MiR-92b-3p Is Induced by Advanced Glycation End Products and Involved in the Pathogenesis of Diabetic Nephropathy. Evid Based Complement Alternat Med. 2020:6050874.
   PubMed Web of Science ®Google Scholar
• Wang R, Fu T, You K, Li S, Zhao N, Yang J, Zhuang SM. 2018. Identification of a TGF-β-miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells. Faseb J. 32(7):3936–3945.
   PubMed Web of Science ®Google Scholar
• Wang W, Dong R, Guo Y, He J, Shao C, Yi P, Yu F, Gu D, Zheng J. 2019. CircMTO1 inhibits liver fibrosis via regulation of miR-17-5p and Smad7. J Cell Mol Med. 23(8):5486–5496.
   PubMed Web of Science ®Google Scholar
• Wang W, Huang XR, Li AG, Liu F, Li JH, Truong LD, Wang XJ, Lan HY. 2005. Signaling mechanism of TGF-β1 in prevention of renal inflammation: Role of Smad7. JASN. 16(5):1371–1383.
   Web of Science ®Google Scholar
• Wang X, Wang H, Cao J, Ye C. 2018. Exosomes from adipose-derived stem cells promotes VEGF-C-dependent lymphangiogenesis by regulating miRNA-132/TGF-β pathway. Cell Physiol Biochem. 49(1):160–171.
   PubMedGoogle Scholar
• Wang XL, Zhao YY, Sun L, Shi Y, Li ZQ, Zhao XD, Xu CG, Ji HG, Wang M, Xu WR, et al. 2018. Exosomes derived from human umbilical cord mesenchymal stem cells improve myocardial repair via upregulation of Smad7. Int J Mol Med. 41(5):3063–3072.
   PubMed Web of Science ®Google Scholar
• Wang Y. 2017. The inhibition of microRNA-15a suppresses hepatitis B virus-associated liver cancer cell growth through the Smad/TGF-β pathway . Oncol Rep. 37(6):3520–3526.
   PubMed Web of Science ®Google Scholar
• Wang ZH, Zhang QS, Duan YL, Zhang JL, Li GF, Zheng DL. 2015. TGF-β induced miR-132 enhances the activation of TGF-β signaling through inhibiting SMAD7 expression in glioma cells. Biochem Biophys Res Commun. 463(3):187–192.
   PubMed Web of Science ®Google Scholar
• Wei B, Wei W, Zhao B, Guo X, Liu S. 2017. Long non-coding RNA HOTAIR inhibits MIR-17-5p to regulate osteogenic differentiation and proliferation in nontraumatic osteonecrosis of femoral head. PLoS One. 12(2):e0169097.
   PubMed Web of Science ®Google Scholar
• Wei Z, Cao J, Zhang X, Yin D, Xu D, Lu G. 2019. EPA Attenuates Epithelial-Mesenchymal Transition and Fibrosis Through the TGF-β1/Smad3/ILK Pathway in Renal Tubular Epithelial HK-2 Cells by Up-Regulating miR-541. Int J Clin Exp Pathol. 12(7):2516–2525.
   PubMed Web of Science ®Google Scholar
• Wicks SJ, Haros K, Maillard M, Song L, Cohen RE, Ten Dijke P, Chantry A. 2005. The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-β signalling. Oncogene. 24(54):8080–8084.
   PubMed Web of Science ®Google Scholar
• Wiesner S, Ogunjimi AA, Wang HR, Rotin D, Sicheri F, Wrana JL, Forman-Kay JD. 2007. Autoinhibition of the HECT-Type Ubiquitin Ligase Smurf2 through Its C2 Domain. Cell. 130(4):651–662.
   PubMed Web of Science ®Google Scholar
• Wojtowicz S, Lee S, Chan E, Ng E, Campbell CI, Di Guglielmo GM. 2020. SMURF2 and SMAD7 induce SARA degradation via the proteasome. Cell Signal. 72:109627
   PubMed Web of Science ®Google Scholar
• Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. 1994. Mechanism of activation of the TGF-β receptor. Nature. 370(6488):341–347.
   PubMed Web of Science ®Google Scholar
• Wu Z, Qiu X, Gao B, Lian C, Peng Y, Liang A, Xu C, Gao W, Zhang L, Su P, et al. 2018. Melatonin-mediated miR-526b-3p and miR-590-5p upregulation promotes chondrogenic differentiation of human mesenchymal stem cells. J Pineal Res. 65(1):e12483.
   PubMed Web of Science ®Google Scholar
• Xia H, Ooi LLPJ, Hui KM. 2013. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology. 58(2):629–641.
   PubMed Web of Science ®Google Scholar
• Xu HM, Sui FH, Sun MH, Guo GL. 2019. Downregulated microRNA-224 aggravates vulnerable atherosclerotic plaques and vascular remodeling in acute coronary syndrome through activation of the TGF-β/Smad pathway. J Cell Physiol. 234(3):2537–2551.
   PubMed Web of Science ®Google Scholar
• Xu J, Ai Q, Cao H, Liu Q. 2015. MiR-185-3p and miR-324-3p predict radiosensitivity of nasopharyngeal carcinoma and modulate cancer cell growth and apoptosis by targeting SMAD7. Med Sci Monit. 21:2828–2836.
   PubMed Web of Science ®Google Scholar
• Xu J, Xu Y. 2017. The lncRNA MEG3 downregulation leads to osteoarthritis progression via miR-16/SMAD7 axis. Cell Biosci. 7(1):69.
   PubMedGoogle Scholar
• Xu P, Lin X, Feng XH. 2016. Posttranslational regulation of smads. Cold Spring Harb Perspect Biol. 8(12):a022087.
   PubMed Web of Science ®Google Scholar
• Yan X, Liao H, Cheng M, Shi X, Lin X, Feng XH, Chen YG. 2016. Smad7 protein interacts with receptor-regulated Smads (R-Smads) to inhibit transforming growth factor-β (TGF-β)/Smad signaling. J Biol Chem. 291(1):382–392.
   PubMed Web of Science ®Google Scholar
• Yanagida A, Iwaisako K, Hatano E, Taura K, Sato F, Narita M, Nagata H, Asechi H, Uemoto S, Kinoshita M. 2011. Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells. Biochim Biophys Acta - Mol Basis Dis. 1812(11):1403–1411.
   Web of Science ®Google Scholar
• Yang D, Ma M, Zhou W, Yang B, Xiao C. 2017. Inhibition of miR-32 activity promoted EMT induced by PM2.5 exposure through the modulation of the Smad1-mediated signaling pathways in lung cancer cells. Chemosphere. 184:289–298.
   PubMed Web of Science ®Google Scholar
• Yang Y, Ding S, Xu G, Chen F, Ding F. 2017. MicroRNA-15a inhibition protects against hypoxia/reoxygenation-induced apoptosis of cardiomyocytes by targeting mothers against decapentaplegic homolog 7. Mol Med Rep. 15(6):3699–3705.
   PubMed Web of Science ®Google Scholar
• Yu D, Shin HS, Lee YS, Lee YC. 2014. MiR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells. Lab Invest. 94(12):1370–1381.
   PubMed Web of Science ®Google Scholar
• Yu F, Guo Y, Chen B, Dong P, Zheng J. 2015. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest. 95(7):781–789.
   PubMed Web of Science ®Google Scholar
• Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, Segura MF, Zhang X, Hu G. 2016. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat Commun. 7(1):13884–13812.
   PubMedGoogle Scholar
• Yu Y, Feng XH. 2019. TGF-β signaling in cell fate control and cancer. Curr Opin Cell Biol. 61:56–63.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Yao J, Li Y, Xue Y, Zou Y, Shu Z, Jiao Z. 2018. Anti-apoptosis endothelial cell-secreted microRNA-195-5p promotes pulmonary arterial smooth muscle cell proliferation and migration in pulmonary arterial hypertension. J Cell Biochem. 119(2):2144–2155.
   PubMed Web of Science ®Google Scholar
• Zhai W, Li S, Zhang J, Chen Y, Ma J, Kong W, Gong D, Zheng J, Xue W, Xu Y. 2018. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. Mol Cancer. 17(1):157
   PubMedGoogle Scholar
• Zhang B, Zhou M, Li C, Zhou J, Li H, Zhu D, Wang Z, Chen A, Zhao Q. 2014. MicroRNA-92a inhibition attenuates hypoxia/reoxygenation-induced myocardiocyte apoptosis by targeting Smad7. PLoS One. 9(6):e100298.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu W, Shen F, Ma X, Liu X, Tian F, Zeng W, Xi X, Lin Y. 2018. The activation of microRNA-520h–associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression. Cell Death Dis. 9(9):1–15.
   PubMedGoogle Scholar
• Zhang J, Ning X, Cui W, Bi M, Zhang D, Zhang J. 2015. Transforming growth factor (TGF)-β-induced microRNA-216a promotes acute pancreatitis via Akt and TGF-β pathway in mice. Dig Dis Sci. 60(1):127–135.
   PubMed Web of Science ®Google Scholar
• Zhang Q. l, Wang W, Li J, Tian SY, Zhang TZ. 2015. Decreased miR-187 induces retinal ganglion cell apoptosis through upregulating SMAD7 in glaucoma. Biomed Pharmacother. 75:19–25.
   PubMed Web of Science ®Google Scholar
• Zhang S, Ekman M, Thakur N, Bu S, Davoodpour P, Grimsby S, Tagami S, Heldin CH, Landström M. 2006. TGFβ1-induced activation of ATM and p53 mediates apoptosis in a Smad7-dependent manner . Cell Cycle. 5(23):2787–2795.
   PubMed Web of Science ®Google Scholar
• Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng X-H, Meng A, Chen Y-G. 2007. Smad7 antagonizes transforming growth factor β signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol. 27(12):4488–4499.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R. 2001. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci USA. 98(3):974–979.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Fan Y, Xie F, Zhou H, Jin K, Shao L, Shi W, Fang P, Yang B, van Dam H, et al. 2017. Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7. Nat Commun. 8(1)
   Google Scholar
• Zhang Z, Jiang H, Li X, Chen X, Huang Y. 2019. MiR‐92a regulates brown adipocytes differentiation, mitochondrial oxidative respiration, and heat generation by targeting SMAD7. J Cell Biochem. jcb.29539.
   Web of Science ®Google Scholar
• Zhang Z, Xue Z, Liu Y, Liu H, Guo X, Li Y, Yang H, Zhang L, Da Y, Yao Z, et al. 2018. MicroRNA-181c promotes Th17 cell differentiation and mediates experimental autoimmune encephalomyelitis. Brain Behav Immun. 70:305–314.
   PubMed Web of Science ®Google Scholar
• Zhao F, Ma X, Qiu W, Wang P, Zhang R, Chen Z, Su P, Zhang Y, Li D, Ma J, et al. 2020. Mesenchymal MACF1 Facilitates SMAD7 Nuclear Translocation to Drive Bone Formation. Cells. 9(3):616.
   Web of Science ®Google Scholar
• Zhao S, Sun H, Jiang W, Mi Y, Zhang D, Wen Y, Cheng D, Tang H, Wu S, Yu Y, et al. 2017. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition. Mol Cancer. 16(1):12
   PubMedGoogle Scholar
• Zhao T, Sun S, Zhang H, Huang X, Yan M, Dong X, Wen Y, Wang H, Lan HY, Li P. 2016. Therapeutic effects of tangshen formula on diabetic nephropathy in rats. PLoS One. 11(1):e0147693.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Thornton AM, Kinney MC, Ma CA, Spinner JJ, Fuss IJ, Shevach EM, Jain A. 2011. The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor β (TGF-β) signaling and the development of regulatory T cells. J Biol Chem. 286(47):40520–40530.
   PubMed Web of Science ®Google Scholar
• Zhong X, Tang J, Li H, Shi X, Wu Y, Xia D, Zhang H, Ye J, Wu H. 2020. MiR-3175 promotes epithelial-mesenchymal transition by targeting Smad7 in human conjunctiva and pterygium. FEBS Lett. 594(7):1207–1217.
   PubMed Web of Science ®Google Scholar
• Zhou G, Lin W, Fang P, Lin X, Zhuge L, Hu Z, Jin L. 2016. MiR-10a improves hepatic fibrosis by regulatingthe TGFβl/smads signal transduction pathway. Exp Ther Med. 12(3):1719–1722.
   PubMed Web of Science ®Google Scholar
• Zhou JY, Zheng SR, Liu J, Shi R, Yu HL, Wei M. 2016. MiR-519d facilitates the progression and metastasis of cervical cancer through direct targeting Smad7. Cancer Cell Int. 16(1).
   Google Scholar
• Zhu B, Wei X, Xia Wang T, Bao Zhou Y, Cai Liu A, Min Zhang G. Wen   2015. Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7. Arch Virol. 160(8):2043–2050.
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhang Z, Zhang Y, Li W, Zheng W, Yu J, Wang B, Chen L, Zhuo Q, Chen L, et al. 2018. MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7. Biochem Biophys Res Commun. 496(1):176–183.
   PubMed Web of Science ®Google Scholar
• Zhu M, Zhang N, He S. 2019. Transcription factor KLF4 modulates microRNA-106a that targets Smad7 in gastric cancer. Pathol Res Pract. 215(8):152467.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Xu Y, Zhao J, Liu Q, Feng W, Fan J, Wang P. 2015. MiR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway. Br J Cancer. 112(8):1367–1375.
   PubMed Web of Science ®Google Scholar
• Zhuang LK, Yang YT, Ma X, Han B, Wang ZS, Zhao QY, Wu LQ, Qu ZQ. 2016. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis. 7(4):e2203–e2203.
   PubMedGoogle Scholar
• Zorzi F, Calabrese E, Monteleone I, Fantini M, Onali S, Biancone L, Pallone F, Monteleone G. 2012. A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn’s disease. Aliment Pharmacol Ther. 36(9):850–857.
   PubMed Web of Science ®Google Scholar
• Zou T, Zhu M, Ma YC, Xiao F, Yu X, Xu L, Ma LQ, Yang J, Dong JZ. 2018. MicroRNA-410-5p exacerbates high-fat diet-induced cardiac remodeling in mice in an endocrine fashion. Sci Rep. 8(1):1–12.
   PubMedGoogle Scholar